Speaker(s): 

Joseph AbouAyash, BS, fourth-year medical student at Geisinger Commonwealth School of Medicine.

Emily Halbedl, BS, Phase 3 student at Geisinger Commonwealth School of Medicine.

Arpitha Pamula, BS, fourth-year medical student at the Geisinger Commonwealth School of Medicine.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Describe conditional survival (CS) and its relevance to chronic limb-threatening ischemia (CLTI).
2. Interpret the clinical significance of major limb amputation within one year of CLTI diagnosis and explain its implications for patient mortality and conditional survival outcomes.
3. Discuss the systemic nature of CLTI as an indicator of advanced progressive atherosclerotic disease and identify potential research directions for exploring surgical intervention impacts on long-term survival.
4. Recognize the prevalence of childhood obesity and the role of current guidelines to treat this disease, including Geisinger's Pediatric Weight Management Program
5. Explore the effects of Geisinger's Pediatric Weight Management Program on BMI measures and medication use.
6. Understand the differences between the anterior (ALIF) and transforaminal (TLIF) techniques.
7. Interpret the analysis of radiographic, patient reported outcomes, and rate of recovery longitudinally between ALIF vs TLIF.
8. Discuss the clinical implications of ALIF vs TLIF based on the result findings and identify potential future research directions.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Candice Laubach, MBA, Christa Martin, PhD, Jennifer Nunamaker, Christian Lynch, MPH, Eric Wright, PharmD, MPH, Adam Buchanan, MS, MPH, CGC, and David Rolston, MD, FACP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Mr. AbouAyash, Ms. Halbedl and Ms. Pamula have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None